An Assessment on Current Outcomes of Peritoneal Dialysis in Korea (PDKOREA)
Status
Conditions
Details and patient eligibility
About
In this study, the recent trends in outcomes according to the dialysis modality in Korea since 2009, the effect of the use of peritoneal dialysis solutions containing icodextrin or high-glucose on various outcomes, the usefulness of 'PD first strategy', and the economic burden according to the dialysis modality will be investigated retrospectively using the Korean Health Insurance Review and Assessment Service (HIRA) database.
Full description
This study is designed as an observational and retrospective cohort study, thus there will be no intervention or specified prescription.
For the comparison of outcomes according to dialysis modality, we will adopt an intention-to-treat analysis, and consider the dialysis modality at day 90 to be the initial dialysis modality. However, the investigators will also regard the dialysis modality at day 30 as the initial dialysis modality in order to evaluate and compare earlier mortality.
Enrollment
Sex
Volunteers
Inclusion criteria
- Patients who started dialysis during the study period and remained on the dialysis therapy for at least 90 days
Exclusion criteria
- Patients who were younger than 18 years of age
- Patients who survived for less than 90 days from the date of dialysis initiation
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal